LeviCell Platform
Powerfully Simple Workflow for Label-Free Sample Enrichment

The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
The LeviCell™ platform is a next generation solution for cellular analysis that delivers simple, label-free cell separation for fast, effective, and gentle enrichment of cells and nuclei from even the most complex samples. The platform can process a broad spectrum of sample types including primary dissociated tissue, fragile or easily stimulated cell types, and even nuclei. Purified cells of interest are reliably recovered regardless of starting cell number, cell viability, or sample purity.
- Simple: 3-step workflow to go from heterogenous sample to purified, viable cells
- Fast: Cells are ready within 20 minutes
- Easy: System requires no calibration and can be self-installed
- Gentle: Ultra-low <1psi pressure maintain cell health and viability
- Innovative: No labels, dyes, beads or high pressure force needed
- Flexible: Adaptable to a range of sample types and application areas
LeviCell - Precision cell enrichment in minutes
Introducing the first platform that purifies cells and nuclei in minutes without any markers or modifications. Prior to running any downstream cellular analysis or expansion, researchers can levitate their sample of interest to focus on the cells that matter – regardless of starting cell number, viability, or purity.
Single-cell genomics at the Memorial Sloan Kettering Cancer Center: Developing innovative methods
Dr. Ronan Chaligné, Head of the Single-Cell Analytics Innovation Laboratory, discusses advances in single-cell methods advancing cancer research
LevitasBio announces the LeviCell EOS System
A new era in sample processing and characterization
Innovative cell technology enabling new discoveries for B-cell leukemia treatment
Dr. Ernesto Diaz-Flores, University of California, discusses his work to identify effective therapies for B-cell leukemia, and the cell enrichment platform transforming his research












